Stay updated with breaking news from Systemic Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release the first quarter...
INSIDE INFORMATION Patent covers the therapeutic use of a new composite formulation of anti-inflammatory compounds with unique advantages BioSenic’s new formulation lowers the dosage of... | April 18, 2023
/PRNewswire/ -- Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, today announced it will present data on its clinical drug candidate,...
INSIDE INFORMATION Mont-Saint-Guibert, Belgium, March 31, 2023, 7am CET - BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in severe autoimmune/inflammatory diseases
BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in severe autoimmune/inflammatory diseases and cellular repair, provides today a financial update and publishes its financial calendar for the year 2023. Financial Update As a result of cost management efforts made and payments ...